mHealth

The global cosmetic surgery market is likely to gain traction from the ever-increasing number of patients undergoing procedures, such as chin augmentation, breast reduction, and breast augmentation. The American Society for Aesthetic Plastic Surgery (ASAPS) declared that in 2018, breast reduction (18%) and chin augmentation (20%) were two of the most popular surgical procedures in the U.S. This information is given by Fortune Business Insights™ in a recent report, titled, “Cosmetic Surgery Market Size, Share & Industry Analysis, By Type (Surgical Procedures, and Non-Surgical Procedures), By Gender (Males, and Females), By End User (Spas & Cosmetic Surgery Centers, and Hospitals & Specialty Clinics), and Regional Forecast, 2019-2026.” The report further states that the cosmetic surgery market size was USD 50.67 billion in 2018 and is projected to reach USD 66.96 billion by 2026, exhibiting a CAGR of 3.6% during the forecast period.

What Does This Report Contain?

• Elaborate information about the factors that would accelerate the market growth in the coming years.
• Comprehensive data about all those factors that are set to pose as growth barriers.
• In-depth analysis of the cosmetic surgery market trends, challenges, and opportunities.
• A thorough analysis of the competitive landscape and profiles of all the vendors.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/cosmetic-surgery-market-102628

Fortune Business Insights™ lists out some of the most reputed companies present in the aesthetic surgery market. They are as follows:

• TETIK
• Westlake Dermatology
• Long Island Plastic Surgical Group, P.C.
• ALLERGAN
• Merz Pharma
• Galderma Laboratories
• Cleveland Clinic
• Other key market players

Drivers & Restraints-

Rising Emphasis on Reduced Post-surgical Interventions to Propel Growth

The market consists of several prominent companies that are presently focusing on capitalizing their market share by delivering new instruments and products to the masses. Besides, the demand for unique products with reduced post-surgical interventions and adverse effects is aiding these companies in investing huge sums in research and development activities.

Furthermore, patients and healthcare providers are nowadays looking for state-of-the-art products. Coupled with this, the rising emphasis on removing the harmful effects of implants and other similar cosmetic procedures would contribute to the aesthetic surgery market growth in the near future. However, the emergence of non-licensed facilities worldwide may hamper the market growth.

An Overview of the Impact of COVID-19 on this Market:

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.

Click here to get the short-term and long-term impact of COVID-19 on this Market Please visit: 

https://www.fortunebusinessinsights.com/cosmetic-surgery-market-102628

Segment-

High Demand for Dermal Fillers Procedure to Accelerate Non-surgical Procedure Segment

In terms of procedure, the market is divided into non-surgical and surgical procedures. Amongst these, in 2018, the surgical procedures segment was in the leading position in the market. Although the number of surgical procedures is much lower than non-surgical procedures across the globe, expensive nature of the former is one of the main factors responsible for high share of the segment. Eyelid surgery, liposuction, and breast augmentation were the top surgical procedures that were performed the most in 2018.

Technological advancements in cardiac rhythm devices are driving the Global Cardiac Rhythm Management Devices Market. Fortune Business Insights in a report, titled “Cardiac Rhythm Management Devices Market: Global Market Analysis, Insights and Forecast, 2019-2026” projects the global market to register a CAGR of 4.4% between 2019 and 2026.

In 2019, The global market was worth US$ 13,883.7 Mn and is anticipated to be worth US$ 19,938.3.1 Mn by 2026. The rising prevalence of cardiovascular disorders across the world is the chief factor responsible for positively impacting the growth of the market.

The report covers:

• Global Cardiac Rhythm Management Devices Market trends, with detailed analysis on consumer trends & manufacturer trends.
• Overview on supply analysis covering trends across raw material suppliers, technology providers and distributors.
• Key areas of investments identifying market opportunities and challenges in forecast timeframe.
• Competitive analysis of the industry players along with the overview on strategic management.
• Comprehensive company profiles of the major industry players.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/cardiac-rhythm-management-devices-market-100679

Leading Players operating in the Cardiac Rhythm Management Devices Market are:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

• Medtronic
• Boston Scientific
• Biotronik
• Philips Healthcare SL
• Defibtech, LLC.
• Cardiac Science
• Stryker
• Medical System
• LivaNova
• Abbott
• Microport

Medtronic Tops Among Other Companies Owing to its Robust Product Portfolio

Physio Control, Cardiac Science, Medtronic, Stryker, CU Medical Systems Inc., Defibtech, LLC., Abbott, Boston Scientific Corporation, MicroPort, BIOTRONIK, and LivaNova PLC are some of the leading players operating in the global cardiac rhythm management devices market. Among these companies, Medtronic is leading the global implantable cardioverter defibrillator market and accounts for a major share in the global pacemaker market.

The wide array of product offerings and their availability are factors responsible for the company’s leading position. These factors, together with the company’s strong customer base, will help the company to emerge dominant during the forecast period. Medtronic together with Boston Scientific Corporation currently holds over half of the share in the global market.

An Overview of the Impact of COVID-19 on this Market:

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.

Click here to get the short-term and long-term impact of COVID-19 on this Market Please visit: https://www.fortunebusinessinsights.com/industry-reports/cardiac-rhythm-management-devices-market-100679

North America Dominates Owing to Favorable Healthcare Reimbursement Policies

From a geographical standpoint, North America is anticipated to dominate the global cardiac rhythm management devices market in the forecast years. Well-established healthcare infrastructure and favourable healthcare reimbursement policies are contributing to the growth of the market. The market in this region was valued at US$ 5,914.1 Mn in the year 2018. Cardiac patients have shifted their focus to preventive care.

This rising shift is fueling demand for cardiac rhythm management devices. In addition to this, governments have made strict guidelines to install external defibrillators, especially in public places. Against this backdrop, the demand for cardiac rhythm management devices is increasing, which will in due course, drive the market.

The global colorectal cancer therapeutics market size is projected to reach USD 16.58 billion by 2026, owing to the rise in the prevalence of colorectal cancer worldwide. A report by Fortune Business Insights™ titled, “Colorectal Cancer Therapeutics Market Size, Share & Industry Analysis, By Therapy (Targeted Therapy, Immunotherapy, Chemotherapy, Others), By Cancer Type (Colorectal Adenocarcinoma, Gastrointestinal Carcinoid Tumors, Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019-2026,” provides a detailed analysis of the same.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/colorectal-cancer-therapeutics-market-101945

Some of the key colorectal cancer drugs market manufacturers include:

• Novartis AG
• Bayer AG
• Merck Sharp & Dohme Corp.
• Bristol Myers Squibb
• Pfizer Inc.
• Genentech, Inc.
• Ipsen Biopharmaceuticals, Inc.
• Regeneron Pharmaceuticals, Inc.
• Taiho Pharmaceutical (Otsuka Pharmaceutical Co., Ltd.)
• Sanofi
• Teva Pharmaceutical Industries Ltd.

According to the report, the colorectal cancer drugs market was valued at USD 9.26 billion in 2018. The forecast period is set from 2019 to 2026, and the market is likely to exhibit a CAGR of 7.6%. As per current colorectal cancer therapeutics market trends, the targeted therapy segment is dominating the market in terms of therapy. This is attributed to the presence of a large number of prominent targeted cancer therapies such as Stivarga, Erbitux, and Avastin.

The report offers a comprehensive overview of the colorectal cancer therapeutics market analysis and its growth trajectories such as drivers, restraints, challenges, and opportunities. Besides that, the report provides a detailed segmentation of the market based on factors such as cancer type, by therapy, distribution channel, and others. It also offers the list of key colorectal cancer drugs market manufacturers and the prime strategies adopted by them to gain a competitive edge in the market.

Request a Sample Copy of Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/colorectal-cancer-therapeutics-market-101945

Launch of Better Therapeutics for Colorectal Cancer to Aid in Expansion of Market

The rise in awareness about colorectal cancer is a major factor driving the colorectal cancer therapeutics market growth. Additionally, the increasing number of corresponding product launches for effective colorectal cancer treatment is further expected to help increase the overall market growth in the forecast period. Moreover, the advent of the latest initiatives aiming to provide effective care of colorectal cancer patients is more likely to aid in the expansion of the market for colorectal cancer drugs. Furthermore, the high mortality rates, coupled with the rising demand for effective cancer therapeutics worldwide, is prognosticated to have a positive effect on the colorectal cancer medications market size in the forthcoming years.

The global mHealth market size is expected to reach USD 293.29 billion by 2026, exhibiting a CAGR of 29.1% during the forecast period.  The increasing penetration of smartphones and smart devices will boost the mHealth market trends during the forecast period. According to Pew Research Center’s first survey of smartphone ownership conducted in 2011, 96% of Americans own a cell phone. Out of which ,81% of the American use smartphones. While roughly three-quarters of U.S. adults own desktop or laptop computers, furthermore, the launch of technologically advanced smartphones and wearable devices will consequently aid the mHealth market share, sates our lead analysts at Fortune Business Insights. For instance, OnePlus launched a new concept phone, the OnePlus Concept One McLaren Edition has various features including electrochromic glass technology. In addition, Fitbit CEO James said in a statement, “We see ourselves evenly split between being a consumer company and being a health company.”

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/mhealth-market-100266

According to the report, published by Fortune Business Insights in a report, titled “mHealth Market Size, Share & Industry Analysis, By Category (By Apps {Disease & Treatment Management, Wellness Management}, By Wearable {Body & Temperature Monitors, Sleep Trackers, Fitness Trackers, Glucose Monitors, BP Monitors, Cardiac Monitors}) By Services Type (Monitoring Services, Fitness & Wellness Solutions, Diagnostic Services, Treatment Services) By Service Provider (mHealth App Companies, Pharmaceutical Companies, Hospitals, Health Insurance) and Regional Forecast, 2019-2026” the market size stood at USD 34.28 billion in 2018. The mHealth market report implements a PESTEL study and SWOT analysis to reveal the stability, restrictions, openings, and threats in the smart building market. Combined with the market analysis proficiencies and data integration with the relevant findings, the report has foretold the robust future growth of the market, and all articulated with geographical and merchandise segments. Moreover, it also shows different procedures and strategies, benefactors and dealers working in the market, explores components convincing market development, generation patterns, and following systems. Additionally, the figures and topics covered in this report are both all-inclusive and reliable for the readers.

Growing Geriatric Population to Spur Business Opportunities for the Market

The increasing demand for mHealth solutions around the globe, owing to its user-friendly benefits and high calling efficiency in handling an emergency situation, will aid the mHealth market revenue in the forthcoming years. The increasing number of mHealth applications such as chronic disease management, remote monitoring owing to its cost-effective advantage will further fuel demand for mHealth solutions in the foreseeable future. The growing geriatric population will also contribute positively to the growth of the market. For instance, people above the age of 65, are more prone to chronic ailments; in the U.S., 40 million people, i.e., around 12.9% of the population is above 65 years. Thus, there is a colossal scope for the mHealth market in the countries where the geriatric population is surging.